| David A Andreone, DPM | |
|
11937 Us Highway 271, Tyler, TX 75708-3154 | |
| (903) 877-7826 | |
| Not Available |
| Full Name | David A Andreone |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 26 Years |
| Location | 11937 Us Highway 271, Tyler, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083786982 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 1481 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The University Of Texas Health Science Center At Tyler | Tyler, TX | Hospital |
| Ut Health East Texas Tyler Regional Hospital | Tyler, TX | Hospital |
| Ut Health East Texas Jacksonville Hospital | Jacksonville, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Etmc Physician Group, Inc. | 4486915600 | 276 |
| University Of Texas Health Science Center At Tyler-facility-physician | 4981699220 | 94 |
News Archive
Islet Sciences, Inc., a biotechnology company engaged in the research, development and commercialization of patented technologies in the field of transplantation therapy for patients with diabetes, today announced that it has exclusively licensed technology from Winthrop University Hospital. This technology is complimentary to the early Beta cell destruction diagnostic that Islet Sciences licensed last month.
UCSF and SEEK Development, a global health and development consulting group based in Berlin, Germany, have launched an international partnership that aims to improve global health by helping to turn scientific evidence into policy and action. The Evidence-to-Policy Initiative, or E2Pi, officially launches this week in San Francisco and Berlin, Germany.
In an analysis of 5-year survival rates among black and white women diagnosed with breast cancer between 1991 and 2005, black women continued to have a lower rate of survival, with most of the difference related to factors including poorer health of black patients at diagnosis and more advanced disease, rather than treatment differences, according to a study in the July 24/31 issue of JAMA.
In a recent study, researchers developed and validated a nanoimmunoassay (NIA) that analyzes 1,024 samples in parallel on a single microfluidic device the size of a USB stick. They detected anti-SARS-CoV-2 IgG antibodies, achieving a sensitivity of 98% and specificity of 100% based on an analysis of 134 pre-pandemic sera (collected in 2013/2014 and 2018) and 155 sera from reverse transcription-polymerase chain reaction (RT-PCR) positive individuals.
Global lung cancer researchers and patient advocates today emphasized that new models of delivering care and communicating about cancer care play an important role in the fight against lung cancer.
› Verified 4 days ago
| Provider Name | University Of Texas Health Science Center At Tyler-facility-physician |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1063400778 PECOS PAC ID: 4981699220 Enrollment ID: O20040416001048 |
News Archive
Islet Sciences, Inc., a biotechnology company engaged in the research, development and commercialization of patented technologies in the field of transplantation therapy for patients with diabetes, today announced that it has exclusively licensed technology from Winthrop University Hospital. This technology is complimentary to the early Beta cell destruction diagnostic that Islet Sciences licensed last month.
UCSF and SEEK Development, a global health and development consulting group based in Berlin, Germany, have launched an international partnership that aims to improve global health by helping to turn scientific evidence into policy and action. The Evidence-to-Policy Initiative, or E2Pi, officially launches this week in San Francisco and Berlin, Germany.
In an analysis of 5-year survival rates among black and white women diagnosed with breast cancer between 1991 and 2005, black women continued to have a lower rate of survival, with most of the difference related to factors including poorer health of black patients at diagnosis and more advanced disease, rather than treatment differences, according to a study in the July 24/31 issue of JAMA.
In a recent study, researchers developed and validated a nanoimmunoassay (NIA) that analyzes 1,024 samples in parallel on a single microfluidic device the size of a USB stick. They detected anti-SARS-CoV-2 IgG antibodies, achieving a sensitivity of 98% and specificity of 100% based on an analysis of 134 pre-pandemic sera (collected in 2013/2014 and 2018) and 155 sera from reverse transcription-polymerase chain reaction (RT-PCR) positive individuals.
Global lung cancer researchers and patient advocates today emphasized that new models of delivering care and communicating about cancer care play an important role in the fight against lung cancer.
› Verified 4 days ago
| Provider Name | Etmc Physician Group, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1609382662 PECOS PAC ID: 4486915600 Enrollment ID: O20180305002106 |
News Archive
Islet Sciences, Inc., a biotechnology company engaged in the research, development and commercialization of patented technologies in the field of transplantation therapy for patients with diabetes, today announced that it has exclusively licensed technology from Winthrop University Hospital. This technology is complimentary to the early Beta cell destruction diagnostic that Islet Sciences licensed last month.
UCSF and SEEK Development, a global health and development consulting group based in Berlin, Germany, have launched an international partnership that aims to improve global health by helping to turn scientific evidence into policy and action. The Evidence-to-Policy Initiative, or E2Pi, officially launches this week in San Francisco and Berlin, Germany.
In an analysis of 5-year survival rates among black and white women diagnosed with breast cancer between 1991 and 2005, black women continued to have a lower rate of survival, with most of the difference related to factors including poorer health of black patients at diagnosis and more advanced disease, rather than treatment differences, according to a study in the July 24/31 issue of JAMA.
In a recent study, researchers developed and validated a nanoimmunoassay (NIA) that analyzes 1,024 samples in parallel on a single microfluidic device the size of a USB stick. They detected anti-SARS-CoV-2 IgG antibodies, achieving a sensitivity of 98% and specificity of 100% based on an analysis of 134 pre-pandemic sera (collected in 2013/2014 and 2018) and 155 sera from reverse transcription-polymerase chain reaction (RT-PCR) positive individuals.
Global lung cancer researchers and patient advocates today emphasized that new models of delivering care and communicating about cancer care play an important role in the fight against lung cancer.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David A Andreone, DPM Po Box 731912, Dallas, TX 75373-1912 Ph: (903) 877-7826 | David A Andreone, DPM 11937 Us Highway 271, Tyler, TX 75708-3154 Ph: (903) 877-7826 |
News Archive
Islet Sciences, Inc., a biotechnology company engaged in the research, development and commercialization of patented technologies in the field of transplantation therapy for patients with diabetes, today announced that it has exclusively licensed technology from Winthrop University Hospital. This technology is complimentary to the early Beta cell destruction diagnostic that Islet Sciences licensed last month.
UCSF and SEEK Development, a global health and development consulting group based in Berlin, Germany, have launched an international partnership that aims to improve global health by helping to turn scientific evidence into policy and action. The Evidence-to-Policy Initiative, or E2Pi, officially launches this week in San Francisco and Berlin, Germany.
In an analysis of 5-year survival rates among black and white women diagnosed with breast cancer between 1991 and 2005, black women continued to have a lower rate of survival, with most of the difference related to factors including poorer health of black patients at diagnosis and more advanced disease, rather than treatment differences, according to a study in the July 24/31 issue of JAMA.
In a recent study, researchers developed and validated a nanoimmunoassay (NIA) that analyzes 1,024 samples in parallel on a single microfluidic device the size of a USB stick. They detected anti-SARS-CoV-2 IgG antibodies, achieving a sensitivity of 98% and specificity of 100% based on an analysis of 134 pre-pandemic sera (collected in 2013/2014 and 2018) and 155 sera from reverse transcription-polymerase chain reaction (RT-PCR) positive individuals.
Global lung cancer researchers and patient advocates today emphasized that new models of delivering care and communicating about cancer care play an important role in the fight against lung cancer.
› Verified 4 days ago
Keith Robert Crandall, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1605 Stafford Dr, Tyler, TX 75703 Phone: 903-941-9247 Fax: 888-503-2519 | |
Thomas F Mccloskey Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1318 Clinic Dr, Tyler, TX 75701 Phone: 903-597-9622 Fax: 903-597-1210 | |
Foot Clinic Of East Texas Pc Podiatrist Medicare: Medicare Enrolled Practice Location: 1828 Ese Loop323 Ste 111, Tyler, TX 75701 Phone: 903-593-0987 Fax: 903-592-3309 | |
Dr. Brandon E. Crim, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 417 S Saunders Ave, Tyler, TX 75702 Phone: 903-596-9173 | |
David A. Andreone Dpm Pllc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 921 Shiloh Road, Ste C110, Tyler, TX 75703 Phone: 903-595-2858 Fax: 903-595-6970 | |
East Texas Podiatry Associates, P.c. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1028 E Idel, Suite A, Tyler, TX 75701 Phone: 903-593-1749 Fax: 903-593-1487 |